Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species

J Biol Chem. 1999 Jul 30;274(31):21840-6. doi: 10.1074/jbc.274.31.21840.

Abstract

Mechanical overload may change cardiac structure through angiotensin II-dependent and angiotensin II-independent mechanisms. We investigated the effects of mechanical strain on the gene expression of tenascin-C, a prominent extracellular molecule in actively remodeling tissues, in neonatal rat cardiac myocytes. Mechanical strain induced tenascin-C mRNA (3.9 +/- 0.5-fold, p < 0.01, n = 13) and tenascin-C protein in an amplitude-dependent manner but did not induce secreted protein acidic and rich in cysteine nor fibronectin. RNase protection assay demonstrated that mechanical strain induced all three alternatively spliced isoforms of tenascin-C. An angiotensin II receptor type 1 antagonist inhibited mechanical induction of brain natriuretic peptide but not tenascin-C. Antioxidants such as N-acetyl-L-cysteine, catalase, and 1, 2-dihydroxy-benzene-3,5-disulfonate significantly inhibited induction of tenascin-C. Truncated tenascin-C promoter-reporter assays using dominant negative mutants of IkappaBalpha and IkappaB kinase beta and electrophoretic mobility shift assays indicated that mechanical strain increases tenascin-C gene transcription by activating nuclear factor-kappaB through reactive oxygen species. Our findings demonstrate that mechanical strain induces tenascin-C in cardiac myocytes through a nuclear factor-kappaB-dependent and angiotensin II-independent mechanism. These data also suggest that reactive oxygen species may participate in mechanically induced left ventricular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / pharmacology
  • Acetylcysteine / pharmacology
  • Alternative Splicing
  • Angiotensin Receptor Antagonists
  • Animals
  • Animals, Newborn
  • Antioxidants / pharmacology*
  • Catalase / pharmacology
  • Cells, Cultured
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Fibronectins / genetics
  • Gene Expression Regulation* / drug effects
  • Genes, Reporter
  • Heart Ventricles
  • I-kappa B Kinase
  • I-kappa B Proteins*
  • Indazoles / pharmacology
  • Myocardium / cytology*
  • Myocardium / metabolism*
  • NF-KappaB Inhibitor alpha
  • Osteonectin / genetics
  • Promoter Regions, Genetic
  • Protein Isoforms / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism*
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Stress, Mechanical
  • Tenascin / biosynthesis
  • Tenascin / genetics*
  • Transcription, Genetic* / drug effects
  • Transfection

Substances

  • Angiotensin Receptor Antagonists
  • Antioxidants
  • DNA-Binding Proteins
  • Fibronectins
  • I-kappa B Proteins
  • Indazoles
  • Nfkbia protein, rat
  • Osteonectin
  • Protein Isoforms
  • RNA, Messenger
  • Reactive Oxygen Species
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Tenascin
  • NF-KappaB Inhibitor alpha
  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
  • Catalase
  • Protein Serine-Threonine Kinases
  • I-kappa B Kinase
  • 7-nitroindazole
  • Acetylcysteine